Business Context and Reporting Period
This Form 8-K was filed by XpresSpa Group, Inc. (not XWELL, Inc.) on March 22, 2019, reporting events occurring on March 18, 2019. The filing addresses a material definitive agreement regarding the company's shareholder rights plan.
Key Financial Metrics
This filing is a current report regarding a corporate governance agreement and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The primary material change reported is the amendment of the Section 382 Rights Agreement (a poison pill defense mechanism). The company extended the "Final Expiration Date" of the agreement from March 18, 2019 to March 19, 2022, subject to other earlier termination events.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of operational risks. The amendment was executed to modify the expiration timeline of the rights agreement. The full text of the amendment is attached as Exhibit 10.1.
Investor Verification Checklist
- Verify the correct registrant name is XpresSpa Group, Inc. (ticker: XSPA), not XWELL, Inc.
- Confirm the new expiration date of the Section 382 Rights Agreement is March 19, 2022.
- Review Exhibit 10.1 for the complete terms of the amendment and any other termination conditions.
- Note that this filing provides no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.